William Eward, MD, DVM, discusses the unmet need for novel agents in tenosynovial giant cell tumor and sarcoma.
William Eward, MD, DVM
Advertisement
Articles by William Eward, MD, DVM
William Eward, MD, DVM, discusses the approval of pexidartinib to treat patients with tenosynovial giant cell tumor.
Advertisement
Latest Updated Articles
Dr. Eward on FDA Approval of Pexidartinib in TGCTOctober 30th 2019
Dr. Eward on the Unmet Need for Novel Agents for TGCT and SarcomaFebruary 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
3
The OncFive: Top Oncology Articles for the Week of 5/31
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5